Oklo Inc. (OKLO) saw its stock surge 5.13% during intraday trading on Wednesday, reflecting strong investor optimism following a major announcement.
The company revealed a partnership with the US Department of Energy (DOE) to design, construct, and operate a radioisotope pilot plant. This facility, part of the DOE's Reactor Pilot Program, will produce medical and research radioisotopes, supporting cancer diagnosis, disease treatment, and medical research in the US.
The agreement underscores Oklo's growing role in strengthening domestic medical supply chains and advancing healthcare innovation, which has bolstered market confidence in the company's future prospects.